Skip to content
Riskpilot
← Back to search
Sign in
Get full access
BRISTOL-MYERS SQUIBB NORWAY AS
AS
Active
Org 891297262
Lysaker Torg 35, 1366
Lysaker
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2007
33 employees
Watchlist
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
BRISTOL-MYERS SQUIBB NORWAY AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AK
Anna Katarina Edsfors Åleskog
Deputy Member
Deputy Member
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
EM
Evristhenis Michalopoulos
Board of Directors
2025
JT
Jens Torup Østby
Chairman
2026
HM
Hilde Mangseth Bech
Chairman
2022
Former (7)
DW
David Walter Pignolet
Board of Directors
2020 – 2021
SM
Swati Mehta
Board of Directors
2022 – 2022
JB
Jörg Boris Schulze
Board of Directors
2023 – 2025
SJ
Stephane Jacques C Strebelle
Board of Directors
2022 – 2022
IL
Iddo Leshem
Board of Directors
2022 – 2022
AC
Abdelhamid Chaaibi
Board of Directors
2022 – 2025
KR
Katherine Reynolds Kelly
Board of Directors
2020 – 2021
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Unknown
Individual
100%
100%
2022
Bristol-Myers Squibb Norway Holding
Company
100%
100%
2023
Bristolmyers Squibb Norway Holdings
Company
100%
100%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on BRISTOL-MYERS SQUIBB NORWAY AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
